C Rad CRAD B.ST · SEK

Its shares trade on Nasdaq Stockholm under the ticker CRAD B.ST. It has been listed since 23 July 2007. In the fiscal year to 31 December 2025, it reported revenue of SEK 441.9m and net income of SEK 10.5m. At that date it held total assets of SEK 500.8m and shareholders' equity of SEK 347.2m.

C-RAD AB engages in the development of innovative solutions for use in advanced radiation therapy. The company is headquartered in Uppsala, Uppsala. The company went IPO on 2007-07-23. The company offers products and solutions to the radiation therapy market. C-Rad AB is the parent company within the C-Rad group (the Group). The Group provides such products, as Sentinel, a surface contour laser scanning system for patient positioning, monitoring and gating applications; Catalyst, a surface scanning system, which allows the identification and tracking of markers, and GEMini, a system based on a gaseous detector using metal converters interleaved with Gas Electron Multipliers (GEMs), as well as other products. The firm operates through several subsidiaries: C-RAD Positioning AB, C-RAD Imaging AB, C-RAD Innovation AB and Cyrpa International Sprl. The Company’s largest shareholder is Inter Life Science AB.

Figures and description from our data supplier, not checked against the company's own report.

• Ms. Kristina WillgardIndependent Chairman of the BoardSEK 495,000
• Ms. Cecilia De LeeuwChief Executive Officer, PresidentSEK 3.7m
• Ms. Linda FrolenChief Financial Officer
• Mr. Ivan AstralagaPresident, C- RAD Americas
• Mr. Xiaodong WangPresident, C- RAD China
• Mr. Hakan AxelssonChief Operating Officer
• Mr. Vincent TallierVice President of Sales - EMEA
• Ms. Melinda PerjonsVice President Global Marketing
• Ms. Anna AmanHR Manager
• Mr. Johan DanielssonDirector Global Services
• Ms. Susanne EkblomIndependent DirectorSEK 245,000
• Ms. Jenny RosbergIndependent DirectorSEK 275,000

Overall

50

Environment

54

Social

59

Governance

37

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.